Melbourne woman suffers acute liver failure after using knock-off drug

A Melbourne woman is fighting for her health in a Victorian hospital after suffering acute liver failure, reportedly triggered by a counterfeit weight-loss drug purchased through an unauthorised seller. Megan Hancocks allegedly acquired the substance, marketed as the peptide retatrutide, via a cash transaction with a local beautician before experiencing a catastrophic systemic reaction just one week after her second dose.

Medical professionals have confirmed the diagnosis of acute hepatic failure, highlighting the extreme volatility of unverified chemical compounds circulating outside of regulated pharmaceutical channels. The incident has sparked urgent warnings from health authorities regarding the rise of ‘black market’ pharmaceuticals and the proliferation of unregulated injectable substances within the Australian cosmetic and wellness industry.

“The intersection of aesthetic pressure and the underground trade of unverified substances has created a precarious landscape where consumer safety is often the first casualty of convenience.”

The Therapeutic Goods Administration (TGA) and local law enforcement are expected to scrutinise the source of the knock-off medication as the investigation continues. Public health experts urge Australians to avoid purchasing any pharmaceutical products from non-medical professionals, stressing that the risks of using unverified peptides far outweigh any perceived cosmetic benefits.